The immune cell landscape in kidneys of patients with lupus nephritis

Arazi, A., Rao, D. A., Berthier, C. C., Davidson, A., Liu, Y., Hoover, P. J., Chicoine, A., Eisenhaure, T. M., Jonsson, A. H., Li, S., Lieb, D. J., Zhang, F., Slowikowski, K., Browne, E. P., Noma, A., Sutherby, D., Steelman, S., Smilek, D. E., Tosta, P., Apruzzese, W., Massarotti, E., Dall’Era, M., Park, M., Kamen,…

Read More

The immune cell landscape in kidneys of patients with lupus nephritis

Arazi, A., Rao, D. A., Berthier, C. C., Davidson, A., Liu, Y., Hoover, P. J., Chicoine, A., Eisenhaure, T. M., Jonsson, A. H., Li, S., Lieb, D. J., Zhang, F., Slowikowski, K., Browne, E. P., Noma, A., Sutherby, D., Steelman, S., Smilek, D. E., Tosta, P., Apruzzese, W., Massarotti, E., Dall’Era, M., Park, M., Kamen,…

Read More

Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease

Huang, Khan, Au, Barber, López-Vásquez, Prokopishyn, Boutin, Rothe, Rip, Abaoui, Nagree, Dworski, Schambach, Keating, West, Klassen, Turner, Sirrs, Rupar, Auray-Blais, Foley, Medin. Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease. Molecular Therapy: Methods & Clinical Development Vol. 5 June 2017. doi:  10.1016/j.omtm.2017.05.003

Read More